ASX:VLA

Email Alerts for:
ASX:VLA

Wall Street closed: Aus shares to extend losses

29 May 2018 - Australian shares are set to fall at the open, amid continuing weakness in oil and a quiet overnight session. The takeover of Viralytics (ASX:VLA) by global pharmaceu…

Viralytics takeover gets FIRB approval

23 May 2018 - The takeover of Viralytics (ASX:VLA) by global pharmaceutical giant, Merck has come one step closer with Merck getting the green light from the Foreign Investment Rev…

Dow tumbles: Aus shares to open lower

23 Apr 2018 - Australian shares are set to open lower today as US share markets fell on Friday, tech stocks and consumer staples were the worst performing sectors. Australian biote…

Continuing a positive streak: Aus shares to open higher

09 Jan 2018 - The Dow closed lower but still had good intraday readings, and the S&P 500 and Nasdaq finished on record highs, as optimism on the US economy remains. Viralytics, (AS…

ASX tips into ten-year high territory: Aus shares close 0.74% higher

05 Jan 2018 - ASX tips into ten-year high territory: Aus shares close 0.74% higher. Bullish US markets drive ASX over 6122. Futures up 53 points. Viralytics Limited (ASX:VLA) raise…

Viralytics cancer trials show strong results

19 Apr 2016 - Viralytics Limited (ASX:VLA) says its CAVATAK treatment coupled with a check point inhibitor is showing strong results in melanoma and lung cancer studies.

Viralytics receives $2.9M tax incentive

10 Dec 2015 - Viralytics Limited (ASX:VLA) receives $2.9 million from the Australian Taxation Office.

Midday: Aus shares 0.9% down at noon

09 Nov 2015 - Aus shares 0.9% down at noon. Recall Holdings Limited (ASX:REC) is on track to deliver earnings and revenue growth.

Viralytics gets approval for Cavatak UK trial

14 Nov 2014 - Viralytics Limtied (ASX:VLA) receives final approval for phase 1 clinical trials of Cavatak from UK regulators for patients with bladder cancer.

Viralytics reports positive Cavatak result

07 Nov 2014 - Viralytics Limited (ASX:VLA) releases results showing improved anti-cancer activity from Cavatak when used in combination with immune checkpoint inhibitors.

M&A, and growing the fintech sector

10 Oct 2014 – There’s a raft of M&A activity this week - while a report examines the strength of the Sydney fintech sector and how it can be grown.

Government assistance & the tech sector

19 Sep 2014 – The government has a disjointed set of grants and assistance packages for tech start-ups but calls are growing for the government to adopt lean startup techniques its…

Viralytics expands patent coverage

05 Feb 2014 - Viralytics Limited (ASX:VLA) expands its patent coverage in the US.

Midday: Aus shares surrender early gains

08 Jan 2014 - Aus shares surrender early gains. Strike Energy Limited (ASX:STX) climbs after its latest drilling results exceed its own expectations.

Market Wrap: ASX closes 0.3% lower

18 Sep 2013 - ASX closes 0.3% lower. Biotech company Viralytics Limited (ASX:VLA) shares soared today on news a significant number of patients responded well to a cancer therapy th…

Viralytics marks drug trial milestone

04 June 2013 - Viralytics Limited (ASX:VLA) says it’s reached a milestone in the clinical trial of a drug for late stage melanoma patients.

Midday: Aus shares relatively unchanged

29 Jul 2011 - Aus shares relatively unchanged. Toll Holdings Limited (ASX:TOL) has refinanced its Singapore debt into a single S$1 billion syndicated debt facility, completely fini…